- 专利标题： MARKER FOR DETERMING CRITICAL STAGE KIDNEY DISEASE
-
申请号： US17286355申请日： 2019-10-17
-
公开(公告)号： US20210373030A1公开(公告)日： 2021-12-02
- 发明人: Masashi MITA , Takashi WADA , Kengo FURUICHI , Norihiko SAKAI , Yasunori IWATA , Shinji KITAJIMA , Yusuke NAKADE
- 申请人： Kagami Inc. , National University Corporation Kanazawa University
- 申请人地址： JP Ibaraki-shi, Osaka; JP Kanazawa-shi, Ishikawa
- 专利权人： Kagami Inc.,National University Corporation Kanazawa University
- 当前专利权人： Kagami Inc.,National University Corporation Kanazawa University
- 当前专利权人地址： JP Ibaraki-shi, Osaka; JP Kanazawa-shi, Ishikawa
- 优先权： JP2018-196250 20181017
- 国际申请： PCT/JP2019/040968 WO 20191017
- 主分类号： G01N33/68
- IPC分类号： G01N33/68 ; G01N33/70
摘要：
The present invention provides: a marker for determining critical stage kidney disease by using an indicator value based on the amount of D-alanine in the blood or the amount of D-alanine and L-alanine therein; a blood analysis method which uses said marker for patients undergoing surgery or intensive care; and a blood analysis system for determining critical stage kidney disease in patients undergoing surgery or intensive care.
信息查询
IPC分类:
